PRIZE DRAW

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

PANEL DISCUSSION: Accelerating Study Start-Up: Driving Operational Readiness and Trial Momentum for Faster Trial Launches

  • Effectively championing adaptive trial designs to stay nimble as the clinical research landscape continues to evolve
  • Streamlining protocol finalization, regulatory submissions, and feasibility assessments to shorten start-up timelines
  • Identifying and engaging the right sites as part of a broader operational readiness strategy
  • Coordinating cross-functional teams, vendor partnerships, and internal stakeholders to ensure smooth study initiation
  • Implementing robust onboarding, training, and communication plans to set the trial up for success from day one
  • Reducing contract cycle times to accelerate study start-up

Moderator: Michael Murphy, Director, Legal & Associate General Counsel, Ionis

Interactive Speaker-Hosted Breakfast Breakout Discussions

With drinks and refreshments, interactive breakout sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will run twice and be led by a table moderator and will focus on a different challenge within clinical trials. Breakout discussions are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

Discussion 1 Turning Inspection Fears into Operational Readiness In An Uncertain Regulatory Environment

Hosted by Regina Griffin, Associate Director, Clinical Operations, Autobahn Therapeutics

Discussion 2 Vendor Oversight – Whose Job Is It Anyways?

Hosted by Denise Deegan, Associate Director, Clinical Operations, Pionyr Immunotherapeutics

Discussion 3

Beyond the Pilot: Turning AI into a Scalable Drug Development Strategy

Hosted by Shivam Patel, Monitoring Oversight and AI Automation Lead, Moderna

Discussion 4 Breaking Down Data Silos: Creating a More Connected Clinical Trial Ecosystem

Hosted by Wei Cheng, Executive Director, Apogee Therapeutics

Discussion 5 Why Patients Walk Away from Clinical Trials and What the Industry Still Gets Wrong

NEW FOR 2026! INDUSTRY HOT TAKES PANEL

This panel will take place in TRACK A: Outsourcing & Clinical Operations

1 stage, a variety of rapid-fire opinions, bold predictions and myth-busting from experts across the industry. Audience members will vote, agree or disagree, on each hot take! There’ll be a chance for the audience to pose some questions to the panel too.

The panel will answer the following:

  • Biggest mistake in clinical trials today
  • One thing pharma should stop doing
  • One prediction for 2030
  • What’s overhyped and what’s worth the hype
  • What vendors misunderstand
  • Where trials fail most often
  • Biggest recruitment mistake
  • Hot takes from the audience

Moderator: Robert Loll, SVP, Business Development & Strategic Planning, Praxis

RFPs and How to Improve the Communication Of Specifications With CROs To Get More Of What You Want And Derisk Your Programs

  • Better RFP specifications lead to better proposals, pricing, timelines, and accountability.
  • The protocol is not the specification, define the operational assumptions CROs need to price and plan accurately.
  • Separate requirements, assumptions, and CRO recommendations so proposals can be compared consistently.
  • Standardize bid grids and key assumptions while still allowing CROs to propose differentiated solutions.
  • Surface exclusions, dependencies, and hidden assumptions early, these are often the source of future change orders.
  • Build uncertainty into the RFP with scenarios for sites, countries, enrollment, timelines, and amendments.
  • Use the RFP and bid defense to test how the CRO thinks, not just what they charge.
  • Carry proposal commitments into the contract, governance plan, KPIs, and operating model.
  • The goal is not simply a better bid, it is better communication, fewer surprises